Ireland
--:--IST
Enrolling by invitation Not applicable

Teaching Doctors in Training to Reason With Artificial Intelligence

NCT07813754 · tracked via the Priya Life Science Israel tracker
Phase
Not applicable
Started
2026-09-24
Last updated
2026-09-25

Condition(s) studied

Artificial Intelligence (AI)Clinical ReasoningClinical Decision-makingMedical Education

Investigational drug(s) / intervention(s)

Workshop-First

Workshop-First: Participants will attend a workshop during their didactic time that will review various aspects of large language models including fundamentals and best practices of interacting and interpreting their outputs.

Study summary

The purpose of the TEACH-AI study is to assess whether a brief, structured workshop on artificial intelligence can improve the performance of medicine doctors in training (i.e. residents) in their diagnostic and management reasoning.

In this multi-site randomized controlled trial, internal medicine and family medicine residents are assigned either to receive an in-person workshop on safe, effective LLM use before a standardized AI-assisted assessment, or to complete the same assessment before receiving the workshop. Residents will review clinical cases that are fully synthetic, no protected health information is used, using a password protected LLM interface.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Participants must be licensed physicians and have started at least post-graduate year 1 (PGY1) of medical training. * Training in Internal medicine or family medicine or emergency medicine. * Able to provide informed consent and complete assessments in English. Exclusion Criteria: * Not currently practicing clinically. * Resident directly involved in the design of the study, development of the workshop, or creation/piloting of the assessment vignettes. * Resident who declines or withdraws consent.

Primary outcome measure(s)

  • Total Score on Expert-Development Rubrics — Within 24 hours of assessment completion.
    The primary outcome will be the number of correct responses for all cases using select questions from expert-developed scoring rubrics. The rubrics were developed using a Delphi consensus process by expert physicians as established by Goh et al (Nature Medicine, 2025; DOI: 10.1038/s41591-024-03456-y). The primary outcome will be analyzed at the case level, comparing performance between the randomized study groups, with a higher number of correct responses indicating a better outcome.

Trial sites (4)

FacilityCityRegionStatus
Stanford University Palo Alto California
AdventHealth Orlando Florida
Beth Israel Deaconess Medical Center Boston Massachusetts
Cambridge Health Alliance Cambridge Massachusetts
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07813754 on ClinicalTrials.gov ↗ ← All trials in Israel